The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Cellular Transformation and Malignancy Induced by ras Require c-jun
Open accessAbstract
ras is an important oncogene in experimental animals and humans. In addition, activated ras proteins are potent inducers of the transcription factor AP-1, which is composed of heterodimeric complexes of Fos and Jun proteins. Together with the fact that deregulated expression of some AP-1 proteins can cause neoplastic transformation, this finding suggests that AP-1 may function as a critical ras effector. We have tested this hypothesis directly by analyzing the response to activated ras in cells that harbor a null mutation in the c-jun gene. The transcriptional response of AP-1-responsive genes to activated ras is severely impaired in c-jun null fibroblasts. Compared with wild-type cells, the c-jun null cells lack many characteristics of ras transformation, including loss of contact inhibition, anchorage independence, and tumorigenicity in nude mice; these properties are restored by forced expression of c-jun. Rare tumorigenic variants of ras-expressing c-jun null fibroblasts do arise. Analysis of these variants reveals a consistent restoration of AP-1 activity. The results provide genetic evidence that c-jun is a crucial effector for transformation by activated ras proteins.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
The small GTP-binding protein rac regulates growth factor-induced membrane ruffling
Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D., & Hall, A. (1992) · Cell · doi:10.1016/0092-8674(92)90164-8 · Cited by 3,616
Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Angel, P. E., Imagawa, M., Chiu, R., Stein, B., Imbra, R. J., Rahmsdorf, H. J., Jonat, C., Herrlich, P. A., & Karin, M. (1987) · Cell · doi:10.1016/0092-8674(87)90611-8 · Cited by 2,930
Purification of Mouse Immunoglobulin Heavy‐Chain Messenger RNAs from Total Myeloma Tumor RNA
Auffray, C., & Rougeon, F. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb06030.x · Cited by 2,626
The stress-activated protein kinase subfamily of c-Jun kinases
Kyriakis, J. M., Banerjee, P. T., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., & Woodgett, J. R. (1994) · Nature · doi:10.1038/369156a0 · Cited by 2,601
T antigen is bound to a host protein in SY40-transformed cells
Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456
Andrews, N. C., & Faller, D. V. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.9.2499 · Cited by 2,292
Morgenstern, J. P., & Land, H. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.12.3587 · Cited by 2,099
Cowley, S. A. (1994) · Cell · doi:10.1016/0092-8674(94)90133-3 · Cited by 1,959
Phosphatidylinositol-3-OH kinase direct target of Ras
Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., & Downward, J. (1994) · Nature · doi:10.1038/370527a0 · Cited by 1,954
Research works printed but not linked: 2
- 10.1128/mcb.11.12.6286-6295.1991 · DOI
- 10.1128/mcb.14.11.7483-7491.1994 · DOI · Paper page
Cited by
Sorted by citations
Signal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237
MAP kinase signalling pathways in cancer
Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210421 · Cited by 2,995
AP-1 as a regulator of cell life and death
Shaulian, E., & Karin, M. (2002) · Nature Cell Biology · doi:10.1038/ncb0502-e131 · Cited by 2,961
Karin, M., Liu, Z.-G., & Zandi, E. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80068-3 · Cited by 2,904
AP-1: a double-edged sword in tumorigenesis
Eferl, R., & Wagner, E. F. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1209 · Cited by 2,218
AP-1 in cell proliferation and survival
Shaulian, E., & Karin, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204383 · Cited by 1,733
Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.
Ryan, H. E., Poloni, M., McNulty, W., Elson, D., Gassmann, M., Arbeit, J. M., & Johnson, R. S. (2000) · PubMed · Cited by 778
Self-citationAP-1 in mouse development and tumorigenesis
Jochum, W., Passegue, E. A., & Wagner, E. F. (2001) · Oncogene · doi:10.1038/sj.onc.1204389 · Cited by 734
c‐Jun regulates cell cycle progression and apoptosis by distinct mechanisms
Wisdom, R., Johnson, R. S., & Moore, C. (1999) · The EMBO Journal · doi:10.1093/emboj/18.1.188 · Cited by 687
Self-citationβ-Catenin Regulates the Expression of the Matrix Metalloproteinase-7 in Human Colorectal Cancer
Brabletz, T., Jung, A., DAĞ, S., Hlubek, F., & Kirchner, T. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65204-2 · Cited by 679
Transcription Factor HIF-1 Is a Necessary Mediator of the Pasteur Effect in Mammalian Cells
Seagroves, T. N., Ryan, H. E., Lu, H., Wouters, B. G., Knapp, M., Thibault, P., Laderoute, K. R., & Johnson, R. S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3436-3444.2001 · Cited by 634
Self-citationTargeting JNK for therapeutic benefit: from junk to gold?
Manning, A. M., & Davis, R. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1132 · Cited by 585
Control of cell cycle progression by c-Jun is p53 dependentPreprint
Schreiber, M., Kolbus, A., Piu, F., Szabowski, A., Möhle-Steinlein, U., Tian, J., Karin, M., Angel, P., & Wagner, E. F. (1999) · Genes & Development · doi:10.1101/gad.13.5.607 · Cited by 576
Hunter, T. R. (1997) · Cell · doi:10.1016/s0092-8674(00)81872-3 · Cited by 553
Ras Protein Farnesyltransferase: A Strategic Target for Anticancer Therapeutic Development
Rowinsky, E. K., Windle, J. J., & Hoff, D. D. V. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3631 · Cited by 533
Requirement of NF-κB Activation to Suppress p53-Independent Apoptosis Induced by Oncogenic Ras
Mayo, M. W., Wang, C.-Y., Cogswell, P. C., Rogers-Graham, K., Lowe, S. W., Der, C. J., & Baldwin, A. S. (1997) · Science · doi:10.1126/science.278.5344.1812 · Cited by 530
Diverse functions of JNK signaling and c-Jun in stress response and apoptosis
Leppä, S., & Bohmann, D. (1999) · Oncogene · doi:10.1038/sj.onc.1203173 · Cited by 522
c-Jun Can Recruit JNK to Phosphorylate Dimerization Partners via Specific Docking Interactions
Kallunki, T., Deng, T., Hibi, M., & Karin, M. (1996) · Cell · doi:10.1016/s0092-8674(00)81999-6 · Cited by 492
Eferl, R., Ricci, R., Kenner, L., Zenz, R., David, J., Rath, M., & Wagner, E. F. (2003) · Cell · doi:10.1016/s0092-8674(03)00042-4 · Cited by 473
A new group of conserved coactivators that increase the specificity of AP-1 transcription factors
Claret, F.-X., Hibi, M., Dhut, S., Toda, T., & Karin, M. (1996) · Nature · doi:10.1038/383453a0 · Cited by 466
Le-Niculescu, H., Bonfoco, E., Kasuya, Y., Claret, F.-X., Green, D. R., & Karin, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.751 · Cited by 460
Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis
van Dam, H., & Castellazzi, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204239 · Cited by 462
Cogswell, P. C., D, D. C. G., Funkhouser, W. K., & Baldwin, A. S. (2000) · Oncogene · doi:10.1038/sj.onc.1203412 · Cited by 452
Laderoute, K. R., Amin, K., Calaoagan, J. M., Knapp, M., Le, T., Orduna, J. M., Foretz, M., & Viollet, B. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00166-06 · Cited by 450
Westwick, J. K., Lambert, Q. T., Clark, G. J., Symons, M. H., Aelst, L. V., Pestell, R. G., & Der, C. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1324 · Cited by 436
eIF3 targets cell-proliferation messenger RNAs for translational activation or repression
Lee, A. S. Y., Kranzusch, P. J., & Cate, J. H. D. (2015) · Nature · doi:10.1038/nature14267 · Cited by 429
Agger, K., Cloos, P. A. C., Rudkjær, L., Williams, K., Andersen, G., Christensen, J., & Helin, K. (2009) · Genes & Development · doi:10.1101/gad.510809 · Cited by 427
AP-1 — The Jun proteins: Oncogenes or tumor suppressors in disguise?
Shaulian, E. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2009.12.008 · Cited by 439
ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility
Vial, E., Sahai, E. A., & Marshall, C. J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00162-4 · Cited by 406
AP-1: One Switch for Many Signals
Wisdom, R. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4685 · Cited by 385
Self-citationFinco, T. S., Westwick, J. K., Norris, J. L., Beg, A. A., Der, C. J., & Baldwin, A. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24113 · Cited by 375
Loss of Cell Polarity Drives Tumor Growth and Invasion through JNK Activation in Drosophila
Igaki, T., Pagliarini, R. A., & Xu, T. (2006) · Current Biology · doi:10.1016/j.cub.2006.04.042 · Cited by 370
Emerging roles of ATF2 and the dynamic AP1 network in cancer
Lopez‐Bergami, P., Lau, E. K., & Ronai, Z. A. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2681 · Cited by 353
The mammalian Jun proteins: redundancy and specificity
Mechta‐Grigoriou, F., Gerald, D., & Yaniv, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204381 · Cited by 340
Sarjeant, K., & Stephens, J. M. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008417 · Cited by 328
Mitogen-Activated Protein Kinase Cascades as Regulators of Stress Responses
Karin, M. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb08987.x · Cited by 327
Transcription factors control invasion: AP-1 the first among equals
Ozanne, B. W., Spence, H. J., McGarry, L., & Hennigan, R. F. (2006) · Oncogene · doi:10.1038/sj.onc.1209759 · Cited by 294
Rewired ERK-JNK Signaling Pathways in Melanoma
Lopez‐Bergami, P., Huang, C. C., Goydos, J. S., Yip, D., Bar‐Eli, M., Herlyn, M., Smalley, K. S. M., Mahale, A. M., Eroshkin, A. M., Aaronson, S. A., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.03.009 · Cited by 285
Olive, M., Krylov, D. Y., Echlin, D. R., Gardner, K. L., Taparowsky, E. J., & Vinson, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18586 · Cited by 282
Oktay, M. H., Wary, K. K., Dans, M. J., Birge, R. B., & Giancotti, F. G. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.7.1461 · Cited by 275
JunD Protects Cells from p53-Dependent Senescence and Apoptosis
Weitzman, J. B., Fiette, L., Matsuo, K., & Yaniv, M. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00109-x · Cited by 269
Grunstein, J., Masbad, J. J., Hickey, R. P., Giordano, F. J., & Johnson, R. S. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.19.7282-7291.2000 · Cited by 253
Self-citationMeyer‐ter‐Vehn, T., Covacci, A., Kist, M., & Pahl, H. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000959200 · Cited by 250
Lee, J. T., & McCubrey, J. A. (2002) · Leukemia · doi:10.1038/sj.leu.2402460 · Cited by 250
Takenaka, Y., Fukumori, T., Yoshii, T., Oka, N., Inohara, H., Kim, H.-R. C., Bresalier, R. S., & Raz, A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.10.4395-4406.2004 · Cited by 229
Grunstein, J., Roberts, W. G., Mathieu-Costello, O. A., Hanahan, D., & Johnson, R. S. (1999) · PubMed · Cited by 222
Self-citationLamb, R. F., Ozanne, B. W., Roy, C., McGarry, L., Stipp, C. S., Mangeat, P. H., & Jay, D. G. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00295-8 · Cited by 211
Regulatory Roles of MAPK Phosphatases in Cancer
Low, H. B., & Zhang, Y. (2016) · Immune Network · doi:10.4110/in.2016.16.2.85 · Cited by 206
Zhu, S., Yoon, K., Sterneck, E., Johnson, P. F., & Smart, R. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012437299 · Cited by 199
Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation
Behrens, A., Jochum, W., Sibilia, M. C., & Wagner, E. F. (2000) · Oncogene · doi:10.1038/sj.onc.1203603 · Cited by 199
The p38 Pathway Provides Negative Feedback for Ras Proliferative Signaling
Chen, G., Hitomi, M., Han, J., & Stacey, D. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002856200 · Cited by 191
Dunn, C. A., Wiltshire, C. J., MacLaren, A., & Gillespie, D. A. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00275-3 · Cited by 187
Activation of the JNK pathway is essential for transformation by the Met oncogene
Rodrigues, G. A., Park, M., & Schlessinger, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2634 · Cited by 187
Increasing Complexity of Ras Signal Transduction: Involvement of Rho Family Proteins
Khosravi‐Far, R., Campbell, S. L., Rossman, K. L., & Der, C. J. (1997) · Advances in cancer research · doi:10.1016/s0065-230x(08)60700-9 · Cited by 182
Cook, S. J., Aziz, N. A., & McMahon, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.330 · Cited by 180
c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor
Behre, G., Whitmarsh, A. J., Coghlan, M. P., Hoang, T., Carpenter, C. L., Zhang, D.-E., Davis, R. J., & Tenen, D. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.4939 · Cited by 180
AP-1-Mediated Invasion Requires Increased Expression of the Hyaluronan Receptor CD44
Lamb, R. F., Hennigan, R. F., Turnbull, K., Katsanakis, K. D., MacKenzie, E. D., Birnie, G. D., & Ozanne, B. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.2.963 · Cited by 173
The 2 Faces of JNK Signaling in Cancer
Tournier, C. (2013) · Genes & Cancer · doi:10.1177/1947601913486349 · Cited by 163
McCarthy, S. A., Chen, D. W., Yang, B.-S., Garcı́a-Ramı́rez, J. J., Cherwinski, H. M., Chen, X., Klagsbrun, M., Hauser, C. A., Ostrowski, M. C., & McMahon, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2401 · Cited by 163
Role of mitogen-activated protein kinase kinase 4 in cancer
Whitmarsh, A. J., & Davis, R. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210410 · Cited by 158
Malliri, A., Symons, M. H., Hennigan, R. F., Hurlstone, A. F. L., Lamb, R. F., Wheeler, T., & Ozanne, B. W. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.4.1087 · Cited by 155
The potential of activator protein 1 (AP-1) in cancer targeted therapy
Song, D., Lian, Y., & Zhang, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1224892 · Cited by 153
Lakshmanan, I., Ponnusamy, M. P., Das, S., Chakraborty, S., Haridas, D., Mukhopadhyay, P., Lele, S. M., & Batra, S. K. (2011) · Oncogene · doi:10.1038/onc.2011.297 · Cited by 153
The oncogene c-Jun impedes somatic cell reprogramming
Liu, J., Han, Q., Peng, T., Peng, M., Wei, B., Li, D., Wang, X., Yu, S., Yang, J., Cao, S., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3193 · Cited by 146
Thépot, D., Weitzman, J. B., Barra, J., Segretain, D., Stinnakre, M., Babinet, C., & Yaniv, M. (2000) · Development · doi:10.1242/dev.127.1.143 · Cited by 147
Zhang, R., Averboukh, L., Zhu, W., Zhang, H., Jo, H., Dempsey, P. J., Coffey, R. J., Pardee, A. B., & Liang, P. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.6131 · Cited by 144
The type I TGF-β receptor is covalently modified and regulated by sumoylation
Kang, J. S., Saunier, E. F., Akhurst, R. J., & Derynck, R. (2008) · Nature Cell Biology · doi:10.1038/ncb1728 · Cited by 148
Ouyang, X., Jessen, W. J., Al‐Ahmadie, H. A., Serio, A. M., Lin, Y., Shih, W. J., Reuter, V. E., Scardino, P. T., Shen, M. M., Aronow, B. J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6055 · Cited by 144
Suppression of Ras-stimulated transformation by the JNK signal transduction pathwayPreprint
Kennedy, N. J., Sluss, H. K., Jones, S. N., Bar‐Sagi, D., Flavell, R. A., & Davis, R. J. (2003) · Genes & Development · doi:10.1101/gad.1062903 · Cited by 139
Shields, J. M., Rogers-Graham, K., & Der, C. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110086200 · Cited by 139
Vial, E., & Marshall, C. J. (2003) · Journal of Cell Science · doi:10.1242/jcs.00812 · Cited by 140
Kravchenko, V. V., Kaufmann, G. F., Mathison, J. C., Scott, D. A., Katz, A. Z., Wood, M. R., Brogan, A. P., Lehmann, M. D., Mee, J. M., Iwata, K., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606613200 · Cited by 132
Toll-like Receptors from the Perspective of Cancer Treatment
Javaid, N., & Choi, S. (2020) · Cancers · doi:10.3390/cancers12020297 · Cited by 138
Laderoute, K. R., Mendonca, H. L., Calaoagan, J. M., Knapp, A. M., Giaccia, A. J., & Stork, P. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12890 · Cited by 127
Echlin, D. R., Tae, H., Mitin, N., & Taparowsky, E. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203491 · Cited by 125
Transcriptional regulation of cell invasion
Ozanne, B. W., McGarry, L., Spence, H. J., Johnston, I., Winnie, J. N., Meagher, L., & Stapleton, G. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00175-1 · Cited by 123
Zhao, H., Wang, J., & To, S. S. T. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3052 · Cited by 122
Qiao, D., Chen, W., Stratagoules, E. D., & Martinez, J. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908890199 · Cited by 121
Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse
Cheng, J., Bai, A., Beckham, T. H., Marrison, S. T., Yount, C. L., Young, K., Lü, P., Bartlett, A. M., Wu, B. X., Keane, B. J., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64791 · Cited by 118
Actions of heparin that may affect the malignant process
Engelberg, H. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990115)85:2 · Cited by 119
The p38 MAPK stress pathway as a tumor suppressor or more?
Loesch, M. (2008) · Frontiers in bioscience · doi:10.2741/2951 · Cited by 115
A human brain tumor-derived PDGFR-α deletion mutant is transforming
Clarke, I. D., & Dirks, P. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206160 · Cited by 108
Burch, P. M., & Heintz, N. H. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.741 · Cited by 110
The response of c-Jun/AP-1 to chronic hypoxia is hypoxia-inducible factor 1α dependent
Laderoute, K. R., Calaoagan, J. M., Gustafson-Brown, C., Knapp, A. M., Li, G.-C., Mendonca, H. L., Ryan, H. E., Wang, Z., & Johnson, R. S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2515-2523.2002 · Cited by 105
Self-citationCloning and characterization of SARI (suppressor of AP-1, regulated by IFN)
Su, Z.-Z., Lee, S., Emdad, L., Lebdeva, I. V., Gupta, P., Valerie, K. C., Sarkar, D., & Fisher, P. B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807975106 · Cited by 104
The E3 ubiquitin ligase Trim7 mediates c-Jun/AP-1 activation by Ras signalling
Chakraborty, A., Diefenbacher, M. E., Mylona, A., Kassel, O., & Behrens, A. (2015) · Nature Communications · doi:10.1038/ncomms7782 · Cited by 102
Chaussepied, M., Lallemand, D., Moreau, M., Adamson, R., Hall, R., & Langsley, G. (1998) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(98)00070-x · Cited by 102
Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation
Gallo, A., Cuozzo, C., Esposito, I., Maggiolini, M., Bonofiglio, D., Vivacqua, A., Garramone, M., Weiß, C., Bohmann, D., & Musti, A. M. (2002) · Oncogene · doi:10.1038/sj.onc.1205822 · Cited by 101
AP‐1: Linking Hydrogen Peroxide and Oxidative Stress
Peroxide, L. H., & Proliferation, O. S. T. T. C. O. C. (2001) · IUBMB Life · doi:10.1080/15216540252774711 · Cited by 101
The Fbxw7/hCdc4 tumor suppressor in human cancer
Tan, Y., Sangfelt, O., & Spruck, C. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.036 · Cited by 101
p120 GAP Modulates Ras Activation of Jun Kinases and Transformation
Clark, G. J., Westwick, J. K., & Der, C. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.3.1677 · Cited by 94
Expression of Glutathione and γ-Glutamylcysteine Synthetase mRNA Is Jun Dependent
Sekhar, K. R., Meredith, M. J., Kerr, L. D., Soltaninassab, S. R., Spitz, D. R., Xu, Z., & Freeman, M. L. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6697 · Cited by 94
JNK Regulates Autocrine Expression of TGF-β1
Ventura, J., Kennedy, N. J., Flavell, R. A., & Davis, R. J. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.06.007 · Cited by 95
Complex Functions of AP-1 Transcription Factors in Differentiation and Survival of PC12 Cells
Leppä, S., Eriksson, M. R., Saffrich, R., Ansorge, W. J., & Bohmann, D. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4369-4378.2001 · Cited by 91
p38γ MAPK Cooperates with c-Jun in trans-Activating Matrix Metalloproteinase 9
Loesch, M., Zhi, H.-Y., Hou, S.-W., Qi, X.-M., Li, R.-S., Basir, Z., Iftner, T., Cuenda, A., & Chen, G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.105429 · Cited by 90
Zoumpourlis, V. C., Papassava, P., Linardopoulos, S., Gillespie, D. A., Balmain, A., & Pintzas, A. (2000) · Oncogene · doi:10.1038/sj.onc.1203732 · Cited by 90
Overexpression of the Tpl-2/Cot oncogene in human breast cancer
Sourvinos, G., Tsatsanis, C., & Spandidos, D. A. (1999) · Oncogene · doi:10.1038/sj.onc.1202891 · Cited by 89
JNK: A Key Modulator of Intracellular Signaling
Vlahopoulos, S., & Zoumpourlis, V. C. (2004) · Biochemistry (Moscow) · doi:10.1023/b:biry.0000040215.02460.45 · Cited by 90
T Cell Deficiency Leads to Liver Carcinogenesis in Azoxymethane-Treated Rats
Wu, B., Ootani, A., Iwakiri, R., Sakata, Y., Fujise, T., Amemori, S., Yokoyama, F., Tsunada, S., Toda, S., & Fujimoto, K. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100111 · Cited by 85
Behre, G., Singh, S. M., Liu, H., Bortolin, L. T., Christopeit, M., Radomska, H. S., Rangatia, J., Hiddemann, W., Friedman, A. D., & Tenen, D. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202301200 · Cited by 82
Metadata
- Authors
- Johnson, R., Spiegelman, B., Hanahan, D., & Wisdom, R.
- Affiliations
- University of California, San Francisco (US)
- Harvard University (US)
- Vanderbilt University (US)
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1996-08
- Volume
- 16
- Issue
- 8
- Pages
- 4504-4511
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC231449
- OpenAlex
- W1895834181
- Cited by
- 282
- References
- 61
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 5 · 2022: 1 · 2021: 4 · 2020: 6 · 2019: 2 · 2018: 3 · 2017: 1 · 2016: 6 · 2015: 7 · 2014: 4 · 2013: 8 · 2012: 2
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Cancer Society
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- c-Jun, oncogenic Ras, AP-1 transcription factor, Fos-Jun heterodimer, oncogenic transformation, anchorage-independent growth, tumorigenicity, Ras effectors
- MeSH terms
- Animals, Base Sequence, Cell Cycle, Cell Transformation, Neoplastic, Cells, Cultured, Molecular Sequence Data, Oligodeoxyribonucleotides, Genes, ras, Proto-Oncogene Proteins p21(ras), Proto-Oncogene Proteins c-jun, Genes, jun, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review